Regulatory News
Wednesday, January 11, 2017
BRIEF-TG therapeutics announces completion of enrollment and B-cell depletion data from part 1 of ongoing phase 2 multiple sclerosis study
* TG therapeutics announces completion of enrollment and
B-cell depletion data from part 1 of ongoing phase 2 multiple
sclerosis study
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment